Preclinical Imaging In Vivo Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Modality (Optical Imaging Systems, Nuclear Imaging Systems, Micro-MRI Systems, Others); Reagents (Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, MRI Contrast Agents, CT Contrast Agents) and Geography

Report Code: TIPMD00002567 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Preclinical Imaging (In-VIVO) Market size will witness a substantial growth in the forecast period with rising investments for monitoring treatment response for early disease diagnosis along with cancer cell detection, bio distribution and drug target. Preclinical imaging (In-VIVO) is gradually used across several drug development processes, with applications ranging from compound optimization, to target identification studies. The use of preclinical imaging (In-VIVO) across several domains will boost the market growth.

MARKET SCOPE

The "Global Preclinical Imaging In Vivo Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Preclinical Imaging In Vivo market with detailed market segmentation by modalities, reagents and geography. The report provides key statistics on the market status of the leading Preclinical Imaging In Vivo market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •   Based on modality, the global Preclinical Imaging In Vivo market is segmented into Optical Imaging Systems, Nuclear Imaging Systems, Micro-MRI Systems and Others.
  •   Based on Reagents, the market is categorised into Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, MRI Contrast Agents, and CT Contrast Agents.

MARKET DYNAMICS
Drivers

  •   Technological innovations such as combination of high resolution MRI with other imaging modalities.
  •   Increasing amount of funding and public-private initiatives in preclinical research activities.

Restraints

  •   High product price leading to decreased adoption rates among academic and research institutions and limited application of each modality.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Preclinical Imaging In Vivo market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Preclinical Imaging In Vivo market in these regions.

IMPACT OF COVID-19 ON PRECLINICAL IMAGING IN VIVO MARKET
As a result of the COVID-19 pandemic many radiology departments have experienced a rapid decline in imaging case volumes. This has important implications on the short-term and long-term economic stability of preclinical imaging procedures across all healthcare practice settings. Due to lockdown imposed by the governments across the world many preclinical procedures were delayed, and supply chain restriction has limited the availability of resources needed to deliver imaging services. Moreover, the COVID-19 pandemic has disrupted the pace of preclinical trials, including delaying diagnoses and therapeutics and in few cases halting clinical trials.

MARKET PLAYERS

The report covers key developments in the Preclinical Imaging In Vivo market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Preclinical Imaging In Vivo market are anticipated to lucrative growth opportunities in the future with the rising demand for Preclinical Imaging In Vivo in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Preclinical Imaging In Vivo market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Takara Bio
  •   Bruker Biospin
  •   Carestream Health
  •   PerkinElmer
  •   Evrogen
  •   Agilent Technologies
  •   BD Biosciences
  •   Berthold Technologies
  •   GE Healthcare
  •   Nikon

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Preclinical Imaging In Vivo Market - By Modality
1.3.2 Preclinical Imaging In Vivo Market - By Reagents
1.3.3 Preclinical Imaging In Vivo Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PRECLINICAL IMAGING IN VIVO MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PRECLINICAL IMAGING IN VIVO MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PRECLINICAL IMAGING IN VIVO MARKET - GLOBAL MARKET ANALYSIS
6.1. PRECLINICAL IMAGING IN VIVO - GLOBAL MARKET OVERVIEW
6.2. PRECLINICAL IMAGING IN VIVO - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. PRECLINICAL IMAGING IN VIVO MARKET - REVENUE AND FORECASTS TO 2028 - MODALITY
7.1. OVERVIEW
7.2. MODALITY MARKET FORECASTS AND ANALYSIS
7.3. OPTICAL IMAGING SYSTEMS
7.3.1. Overview
7.3.2. Optical Imaging Systems Market Forecast and Analysis
7.4. NUCLEAR IMAGING SYSTEMS
7.4.1. Overview
7.4.2. Nuclear Imaging Systems Market Forecast and Analysis
7.5. MICRO-MRI SYSTEMS
7.5.1. Overview
7.5.2. Micro-MRI Systems Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. PRECLINICAL IMAGING IN VIVO MARKET - REVENUE AND FORECASTS TO 2028 - REAGENTS
8.1. OVERVIEW
8.2. REAGENTS MARKET FORECASTS AND ANALYSIS
8.3. PRECLINICAL OPTICAL IMAGING REAGENTS
8.3.1. Overview
8.3.2. Preclinical Optical Imaging Reagents Market Forecast and Analysis
8.4. PRECLINICAL NUCLEAR IMAGING REAGENTS
8.4.1. Overview
8.4.2. Preclinical Nuclear Imaging Reagents Market Forecast and Analysis
8.5. MRI CONTRAST AGENTS
8.5.1. Overview
8.5.2. MRI Contrast Agents Market Forecast and Analysis
8.6. CT CONTRAST AGENTS
8.6.1. Overview
8.6.2. CT Contrast Agents Market Forecast and Analysis
9. PRECLINICAL IMAGING IN VIVO MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Preclinical Imaging In Vivo Market Overview
9.1.2 North America Preclinical Imaging In Vivo Market Forecasts and Analysis
9.1.3 North America Preclinical Imaging In Vivo Market Forecasts and Analysis - By Modality
9.1.4 North America Preclinical Imaging In Vivo Market Forecasts and Analysis - By Reagents
9.1.5 North America Preclinical Imaging In Vivo Market Forecasts and Analysis - By Countries
9.1.5.1 United States Preclinical Imaging In Vivo Market
9.1.5.1.1 United States Preclinical Imaging In Vivo Market by Modality
9.1.5.1.2 United States Preclinical Imaging In Vivo Market by Reagents
9.1.5.2 Canada Preclinical Imaging In Vivo Market
9.1.5.2.1 Canada Preclinical Imaging In Vivo Market by Modality
9.1.5.2.2 Canada Preclinical Imaging In Vivo Market by Reagents
9.1.5.3 Mexico Preclinical Imaging In Vivo Market
9.1.5.3.1 Mexico Preclinical Imaging In Vivo Market by Modality
9.1.5.3.2 Mexico Preclinical Imaging In Vivo Market by Reagents
9.2. EUROPE
9.2.1 Europe Preclinical Imaging In Vivo Market Overview
9.2.2 Europe Preclinical Imaging In Vivo Market Forecasts and Analysis
9.2.3 Europe Preclinical Imaging In Vivo Market Forecasts and Analysis - By Modality
9.2.4 Europe Preclinical Imaging In Vivo Market Forecasts and Analysis - By Reagents
9.2.5 Europe Preclinical Imaging In Vivo Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Preclinical Imaging In Vivo Market
9.2.5.1.1 Germany Preclinical Imaging In Vivo Market by Modality
9.2.5.1.2 Germany Preclinical Imaging In Vivo Market by Reagents
9.2.5.2 France Preclinical Imaging In Vivo Market
9.2.5.2.1 France Preclinical Imaging In Vivo Market by Modality
9.2.5.2.2 France Preclinical Imaging In Vivo Market by Reagents
9.2.5.3 Italy Preclinical Imaging In Vivo Market
9.2.5.3.1 Italy Preclinical Imaging In Vivo Market by Modality
9.2.5.3.2 Italy Preclinical Imaging In Vivo Market by Reagents
9.2.5.4 Spain Preclinical Imaging In Vivo Market
9.2.5.4.1 Spain Preclinical Imaging In Vivo Market by Modality
9.2.5.4.2 Spain Preclinical Imaging In Vivo Market by Reagents
9.2.5.5 United Kingdom Preclinical Imaging In Vivo Market
9.2.5.5.1 United Kingdom Preclinical Imaging In Vivo Market by Modality
9.2.5.5.2 United Kingdom Preclinical Imaging In Vivo Market by Reagents
9.2.5.6 Rest of Europe Preclinical Imaging In Vivo Market
9.2.5.6.1 Rest of Europe Preclinical Imaging In Vivo Market by Modality
9.2.5.6.2 Rest of Europe Preclinical Imaging In Vivo Market by Reagents
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Preclinical Imaging In Vivo Market Overview
9.3.2 Asia-Pacific Preclinical Imaging In Vivo Market Forecasts and Analysis
9.3.3 Asia-Pacific Preclinical Imaging In Vivo Market Forecasts and Analysis - By Modality
9.3.4 Asia-Pacific Preclinical Imaging In Vivo Market Forecasts and Analysis - By Reagents
9.3.5 Asia-Pacific Preclinical Imaging In Vivo Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Preclinical Imaging In Vivo Market
9.3.5.1.1 Australia Preclinical Imaging In Vivo Market by Modality
9.3.5.1.2 Australia Preclinical Imaging In Vivo Market by Reagents
9.3.5.2 China Preclinical Imaging In Vivo Market
9.3.5.2.1 China Preclinical Imaging In Vivo Market by Modality
9.3.5.2.2 China Preclinical Imaging In Vivo Market by Reagents
9.3.5.3 India Preclinical Imaging In Vivo Market
9.3.5.3.1 India Preclinical Imaging In Vivo Market by Modality
9.3.5.3.2 India Preclinical Imaging In Vivo Market by Reagents
9.3.5.4 Japan Preclinical Imaging In Vivo Market
9.3.5.4.1 Japan Preclinical Imaging In Vivo Market by Modality
9.3.5.4.2 Japan Preclinical Imaging In Vivo Market by Reagents
9.3.5.5 South Korea Preclinical Imaging In Vivo Market
9.3.5.5.1 South Korea Preclinical Imaging In Vivo Market by Modality
9.3.5.5.2 South Korea Preclinical Imaging In Vivo Market by Reagents
9.3.5.6 Rest of Asia-Pacific Preclinical Imaging In Vivo Market
9.3.5.6.1 Rest of Asia-Pacific Preclinical Imaging In Vivo Market by Modality
9.3.5.6.2 Rest of Asia-Pacific Preclinical Imaging In Vivo Market by Reagents
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Preclinical Imaging In Vivo Market Overview
9.4.2 Middle East and Africa Preclinical Imaging In Vivo Market Forecasts and Analysis
9.4.3 Middle East and Africa Preclinical Imaging In Vivo Market Forecasts and Analysis - By Modality
9.4.4 Middle East and Africa Preclinical Imaging In Vivo Market Forecasts and Analysis - By Reagents
9.4.5 Middle East and Africa Preclinical Imaging In Vivo Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Preclinical Imaging In Vivo Market
9.4.5.1.1 South Africa Preclinical Imaging In Vivo Market by Modality
9.4.5.1.2 South Africa Preclinical Imaging In Vivo Market by Reagents
9.4.5.2 Saudi Arabia Preclinical Imaging In Vivo Market
9.4.5.2.1 Saudi Arabia Preclinical Imaging In Vivo Market by Modality
9.4.5.2.2 Saudi Arabia Preclinical Imaging In Vivo Market by Reagents
9.4.5.3 U.A.E Preclinical Imaging In Vivo Market
9.4.5.3.1 U.A.E Preclinical Imaging In Vivo Market by Modality
9.4.5.3.2 U.A.E Preclinical Imaging In Vivo Market by Reagents
9.4.5.4 Rest of Middle East and Africa Preclinical Imaging In Vivo Market
9.4.5.4.1 Rest of Middle East and Africa Preclinical Imaging In Vivo Market by Modality
9.4.5.4.2 Rest of Middle East and Africa Preclinical Imaging In Vivo Market by Reagents
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Preclinical Imaging In Vivo Market Overview
9.5.2 South and Central America Preclinical Imaging In Vivo Market Forecasts and Analysis
9.5.3 South and Central America Preclinical Imaging In Vivo Market Forecasts and Analysis - By Modality
9.5.4 South and Central America Preclinical Imaging In Vivo Market Forecasts and Analysis - By Reagents
9.5.5 South and Central America Preclinical Imaging In Vivo Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Preclinical Imaging In Vivo Market
9.5.5.1.1 Brazil Preclinical Imaging In Vivo Market by Modality
9.5.5.1.2 Brazil Preclinical Imaging In Vivo Market by Reagents
9.5.5.2 Argentina Preclinical Imaging In Vivo Market
9.5.5.2.1 Argentina Preclinical Imaging In Vivo Market by Modality
9.5.5.2.2 Argentina Preclinical Imaging In Vivo Market by Reagents
9.5.5.3 Rest of South and Central America Preclinical Imaging In Vivo Market
9.5.5.3.1 Rest of South and Central America Preclinical Imaging In Vivo Market by Modality
9.5.5.3.2 Rest of South and Central America Preclinical Imaging In Vivo Market by Reagents
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PRECLINICAL IMAGING IN VIVO MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. PRECLINICAL IMAGING IN VIVO MARKET, KEY COMPANY PROFILES
12.1. TAKARA BIO
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BRUKER BIOSPIN
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. CARESTREAM HEALTH
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. PERKINELMER
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. EVROGEN
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. AGILENT TECHNOLOGIES
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BD BIOSCIENCES
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BERTHOLD TECHNOLOGIES
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. GE HEALTHCARE
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. NIKON
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS

The List of Companies

1. Takara Bio,
2. Bruker Biospin,
3. Carestream Health,
4. PerkinElmer,
5. Evrogen,
6. Agilent Technologies,
7. BD Biosciences,
8. Berthold Technologies,
9. GE Healthcare,
10. Nikon,
TIPMD00002567
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking